2MTN | Solution structure of MLL-IBD complex | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Cierpicki, T., Pollock, J., Murai, M. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
Primary reference | The same site on LEDGF IBD domain represents therapeutic target for MLL leukemia and HIV., Murai MJ, Pollock J, He S, Miao H, Purohit T, Yokom A, Hess JL, Muntean AG, Grembecka J, Cierpicki T, Blood. 2014 Oct 10. pii: blood-2014-01-550079. PMID:25305204 |
Data retrieval |
View 2MTN in 3D |
Visual 3D analysis of 2MTN |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2MTN |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |